Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review

American Journal Geriatric Pharmacotherapy

Volumn 7, Issue 5, 2009, Pages 250-261

  Shah, Kairav ^a,b   Qureshi, Salah U ^b,c,d,e   Johnson, Michael ^f   Parikh, Niraj ^g   Schulz, Paul E ^b,d   Kunik, Mark E ^b,c,d,e  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Houston Center for Quality of Care and Utilization Studies   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e EDUCATION AND CLINICAL CENTER   (United States)

^f UNIVERSITY OF HOUSTON   (United States)

^g ANALYSIS GROUP   (United States)

Author keywords

antihypertensive drugs; incidence or progression of dementia

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CAPTOPRIL; CLONIDINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FELODIPINE; HYDROCHLOROTHIAZIDE; IMIDAPRIL; INDAPAMIDE; ISRADIPINE; NICARDIPINE; NIFEDIPINE; NILVADIPINE; NIMODIPINE; NITRENDIPINE; PERINDOPRIL; PLACEBO; POTASSIUM SPARING DIURETIC AGENT; VERAPAMIL;

ADD ON THERAPY; ALZHEIMER DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; COMBINATION CHEMOTHERAPY; DEMENTIA; DISEASE COURSE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG USE; HUMAN; HYPERTENSION; INCIDENCE; MONOTHERAPY; MULTIINFARCT DEMENTIA; NEUROPROTECTION; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SYSTEMATIC REVIEW;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIHYPERTENSIVE AGENTS; CLINICAL TRIALS AS TOPIC; DEMENTIA; DEMENTIA, VASCULAR; DISEASE PROGRESSION; HUMANS; HYPERTENSION; INCIDENCE; MIDDLE AGED; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 71749121407     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2009.11.001     Document Type: Review

References (32)

1. Ferri C.P., Prince M., Brayne C., et al., Alzheimer's Disease International. Global prevalence of dementia: A Delphi consensus study. Lancet 366 (2005) 2112-2117
2. Langa K.M., Chernew M.E., Kabeto M.U., et al. National estimates of the quantity and cost of informal caregiving for the elderly with dementia. J Gen Intern Med. 16 (2001) 770-778
3. Koedam E.L., Pijnenburg Y.A., Deeg D.J., et al. Early-onset dementia is associated with higher mortality. Dement Geriatr Cogn Disord. 26 (2008) 147-152
4. Kalaria R.N., Maestre G.E., Arizaga R., et al., World Federation of Neurology Dementia Research Group. Alzheimer's disease and vascular dementia in developing countries: Prevalence, management, and risk factors [published correction appears in Lancet Neurol. 2008;7:867]. Lancet Neurol. 7 (2008) 812-826
5. Whitehouse P.J., Sciulli C.G., and Mason R.M. Dementia drug development: Use of information systems to harmonize global drug development. Psychopharmacol Bull. 33 (1997) 129-133
6. Hendrie H.C. Epidemiology of dementia and Alzheimer's disease. Am J Geriatr Psychiatry. 6 Suppl 1 (1998) S3-S18
7. Launer L.J., Masaki K., Petrovitch H., et al., Honolulu-Asia Aging Study. The association between midlife blood pressure levels and late-life cognitive function. JAMA 274 (1995) 1846-1851
8. Elias M.F., Wolf P.A., D'Agostino R.B., et al. Untreated blood pressure level is inversely related to cognitive functioning: The Framingham Study. Am J Epidemiol. 138 (1993) 353-364
9. Skoog I., Lernfelt B., Landahl S., et al. 15-Year longitudinal study of blood pressure and dementia. Lancet 347 (1996) 1141-1145
10. Kilander L., Nyman H., Boberg M., et al. Hypertension is related to cognitive impairment: A 20-year follow-up of 999 men. Hypertension 31 (1998) 780-786
11. Posner H.B., Tang M.X., Luchsinger J., et al. The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. Neurology 58 (2002) 1175-1181
12. Kanowski S. Aging, dementia and calcium metabolism. J Neural Transm Suppl. 54 (1998) 195-200
13. Zhang J.T. Altered calcium homeostasis in brain aging and senile dementia, new approach to treat Alzheimer's disease [in Chinese]. Yao Xue Xue Bao. 28 (1993) 641-646
14. 2+ channel activity in brain aging and dementia. Hormonal and pharmacologic modulation. Ann NY Acad Sci. 747 (1994) 351-364
15. Takeda S., Sato N., Ogihara T., and Morishita R. The renin-angiotensin system, hypertension and cognitive dysfunc- tion in Alzheimer's disease: New therapeutic potential. Front Biosci. 13 (2008) 2253-2265
16. Kehoe P.G., and Wilcock G.K. Is inhibition of the reninangiotensin system a new treatment option for Alzheimer's disease?. Lancet Neurol. 6 (2007) 373-378
17. Savaskan E. The role of the brain renin-angiotensin system in neurodegenerative disorders. Curr Alzheimer Res. 2 (2005) 29-35
18. Jadad A.R., Moore R.A., Carroll D., et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?. Control Clin Trials. 17 (1996) 1-12
19. Ohrui T., Tomita N., Sato-Nakagawa T., et al. Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression. Neurology 63 (2004) 1324-1325
20. Yasar S., Corrada M., Brookmeyer R., and Kawas C. Calcium channel blockers and risk of AD: The Baltimore Longitudinal Study of Aging. Neurobiol Aging. 26 (2005) 157-163
21. Hajjar I., Catoe H., Sixta S., et al. Cross-sectional and longitudinal association between antihypertensive medications and cognitive impairment in an elderly population. J Gerontol A Biol Sci Med Sci. 60 (2005) 67-73
22. Khachaturian A.S., Zandi P.P., Lyketsos C.G., et al. Antihypertensive medication use and incident Alzheimer disease: The Cache County Study. Arch Neurol. 63 (2006) 686-692
23. Qiu C., Winblad B., Marengoni A., et al. Heart failure and risk of dementia and Alzheimer disease: A populationbased cohort study. Arch Intern Med. 166 (2006) 1003-1008
24. Hanon O., Pequignot R., Seux M.L., et al. Relationship between antihypertensive drug therapy and cognitive function in elderly hypertensive patients with memory complaints. J Hypertens. 24 (2006) 2101-2107
25. Tzourio C., Anderson C., Chapman N., et al., PROGRESS Collaborative Group. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med. 163 (2003) 1069-1075
26. Pantoni L., del Ser T., Soglian A.G., et al. Efficacy and safety of nimodipine in subcortical vascular dementia: A randomized placebo-controlled trial. Stroke 36 (2005) 619-624
27. Guo Z., Fratiglioni L., Zhu L., et al. Occurrence and progression of dementia in a community population aged 75 years and older: Relationship of antihypertensive medication use. Arch Neurol. 56 (1999) 991-996
28. Forette F., Seux M.L., Staessen J.A., et al., Systolic Hypertension in Europe Investigators. The prevention of dementia with antihypertensive treatment: New evidence from the Systolic Hypertension in Europe (Syst-Eur) study [published correction appears in Arch Intern Med. 2003;163:241]. Arch Intern Med. 162 (2002) 2046-2052
29. Skoog I., Lithell H., Hansson L., et al., SCOPE Study Group. Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE). Am J Hypertens. 18 (2005) 1052-1059
30. Peters R., Beckett N., Forette F., et al., HYVET investigators. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): A doubleblind, placebo controlled trial. Lancet Neurol. 7 (2008) 683-689
31. McKhann G., Drachman D., Folstein M., et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
32. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 265 (1991) 3255-3264